How can biofilm dispersal be targeted for therapeutic intervention?

The emergence of colistin-resistant Pseudomonas aeruginosa in cystic fibrosis (CF) patients, particularly after long-term inhalation treatments, has been ... Some types of Pseudomonas have developed resistance to carbapenems, and these bacteria are called carbapenem-resistant Pseudomonas aeruginosa (CRPA). P. aeruginosa infection in the hospital manifests primarily as acute lung infection in patients in intensive care units. Models of pseudomonal pneumonia have ... Some Pseudomonas aeruginosa bacteria are resistant to carbapenem antibiotics, which are often reserved for serious infections. These are called carbapenem- ... Pseudomonas infection ... Pseudomonas is a germ found in the environment. It can occur in moist areas such as sinks or baths. It rarely causes illness outside a ... Pseudomonas aeruginosa is an important nosocomial pathogen that causes serious nosocomial infections and contributes significantly to morbidity and mortality. Pseudomonas aeruginosa is a free-living, aerobic and motile Gram-negative rod bacterium. It is the cause of several disorders in animals and human. 2 Ratjen F, Munck A, Kho P, Angyalosi G. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax. 2010 ... In this paper, we rigorously explore the role of two major bacterial adhesins, type IV pili (Tfp) and flagella, in bacterial adherence to distinct host ... Pseudomonas aeruginosa are strains of bacteria that are widely found in the environment. Pseudomonas is a major cause of lung infections in people with ...